INDUCTION OF FC-GAMMA-R-III (CD16) EXPRESSION ON NEUTROPHILS AFFECTED BY PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA BY ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR

被引:11
作者
NINOMIYA, H
MURAKI, Y
SHIBUYA, K
NAGASAWA, T
ABE, T
机构
[1] Division of Haematology, Institute of Clinical Medicine, University of Tsukuba, Ibaraki
关键词
D O I
10.1111/j.1365-2141.1993.tb03107.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The inducibility of glycosyl-phosphatidylinositol (GPI)-anchored proteins on affected paroxysmal nocturnal haemoglobinuria (PNH) neutrophils (PMN) after both in vitro and in vivo stimulation was investigated. FcgammaR-III (CD16), decay-accelerating factor (DAF/CD55)and 20 kD homologous restriction factor (HRF20/CD59) were demonstrated to be concurrently deficient on unstimulated defective PNH PMN. Upon in vitro stimulation with either N-formyl-methionyl-leucyl-phenylalanine (fMLP), zymosan-activated serum (ZAS), or recombinant human granulocyte colony-stimulation factor (G-CSF), neither CD16 nor CD55 expression was induced on defective PNH PMN. G-CSF was administered to two patients with PNH when their conditions were complicated by bacterial infections, or to prevent infections associated with the extraction of teeth or cataract surgery. CD16 expression was induced on the defective PNH PMN in both cases during the administration of G-CSF, but the expression of CD55 and CD59 was not. CD16, induced on the defective PNH PMN during the administration of G-CSF, was phosphatidylinositol-specific phospholipase C (PIPLC)-sensitive, implying that it had GPI-linkage to the membranes. The patients treated with G-CSF recovered from infection or evaded infection. These observations suggest that a deficiency of GPI-anchored proteins is not always seen in defective PNH blood cells, at least under certain stimulation conditions.
引用
收藏
页码:497 / 503
页数:7
相关论文
共 34 条
[1]   INCREASED EXPRESSION OF COMPLEMENT DECAY-ACCELERATING FACTOR DURING ACTIVATION OF HUMAN-NEUTROPHILS [J].
BERGER, M ;
MEDOF, ME .
JOURNAL OF CLINICAL INVESTIGATION, 1987, 79 (01) :214-220
[2]  
BOYUM A, 1968, SCAND J CLIN LAB INV, VS 21, P77
[3]   SYNTHESIS OF ABERRANT DECAY-ACCELERATING FACTOR PROTEINS BY AFFECTED PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA LEUKOCYTES [J].
CAROTHERS, DJ ;
HAZRA, SV ;
ANDRESON, SW ;
MEDOF, ME .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 85 (01) :47-54
[4]   AN ABNORMALITY OF THE GENE THAT ENCODES NEUTROPHIL FC-RECEPTOR-III IN A PATIENT WITH SYSTEMIC LUPUS-ERYTHEMATOSUS [J].
CLARK, MR ;
LIU, L ;
CLARKSON, SB ;
ORY, PA ;
GOLDSTEIN, IM .
JOURNAL OF CLINICAL INVESTIGATION, 1990, 86 (01) :341-346
[5]   COMPLEMENT (C5A)-INDUCED GRANULOCYTE AGGREGATION INVITRO - POSSIBLE MECHANISM OF COMPLEMENT-MEDIATED LEUKOSTASIS AND LEUKOPENIA [J].
CRADDOCK, PR ;
HAMMERSCHMIDT, D ;
WHITE, JG ;
DALMASSO, AP ;
JACOB, HS .
JOURNAL OF CLINICAL INVESTIGATION, 1977, 60 (01) :260-264
[6]  
DEMETRI GD, 1991, BLOOD, V78, P2791
[7]  
DESANDRE G, 1960, BRIT J HAEMATOL, V6, P39
[8]   PREFERENTIAL EXPRESSION OF HUMAN FC-GAMMA-RIIIPMN (CD16) IN PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA - DISCORDANT EXPRESSION OF GLYCOSYL PHOSPHATIDYLINOSITOL-LINKED PROTEINS [J].
EDBERG, JC ;
SALMON, JE ;
WHITLOW, M ;
KIMBERLY, RP ;
BARINSKY, M ;
TRISCARI, C .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (01) :58-67
[9]   THE MECHANISM OF ACTION OF DECAY-ACCELERATING FACTOR (DAF) DAF INHIBITS THE ASSEMBLY OF C-3 CONVERTASES BY DISSOCIATING C2A AND BB [J].
FUJITA, T ;
INOUE, T ;
OGAWA, K ;
IIDA, K ;
TAMURA, N .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (05) :1221-1228
[10]   SYNTHESIS OF MANNOSYLGLUCOSAMINYLINOSITOL PHOSPHOLIPIDS IN NORMAL BUT NOT PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA CELLS [J].
HIROSE, S ;
RAVI, L ;
PRINCE, GM ;
ROSENFELD, MG ;
SILBER, R ;
ANDRESEN, SW ;
HAZRA, SV ;
MEDOF, ME .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (13) :6025-6029